Pacira Pharmaceuticals (Nasdaq: PCRX) reported Q4 loss of $12.27, versus the analyst estimate of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE